The Valley Desk

NCT07608354 · Interventional trial

A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM

Overall registry status Active not recruiting

Phase 2

Conditions Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov